Investor Relations

Press Releases

All Releases
View Summary OPKO Investee SciVac Ltd. Enters into Transaction with Levon Resources
Mar 23, 2015
PDF 11.1 KB
View Summary OPKO Lab Receives Accreditation From College of American Pathologists
Mar 18, 2015
PDF 13.3 KB
View Summary Phase 3 Data Supporting Rayaldee As a Treatment for Secondary Hyperparathyroidism in Chronic Kidney Disease to be Presented at ENDO 2015 Conference
Mar 6, 2015
PDF 12.7 KB
View Summary Twelve Months Data Supporting Once-Weekly Dosing of hGH-CTP in Growth Hormone Deficient Pediatric Population to Be Presented at ENDO 2015 Conference
Mar 3, 2015
PDF 12.5 KB
View Summary OPKO Announces Fourth Quarter Operating and Financial Results
Feb 27, 2015
PDF 26.7 KB
View Summary OPKO to Announce Fourth Quarter and Full Year 2014 Financial Results on February 27, 2015
Feb 26, 2015
PDF 10.4 KB
View Summary OPKO Announces Publication of 20 Year Outcome Study for Lethal Prostate Cancer Using Kallikrein Biomarkers in 4Kscore Test
Feb 20, 2015
PDF 13.4 KB
View Summary OPKO Health to Present at the 2015 RBC Capital Markets' Healthcare Conference
Feb 13, 2015
PDF 8.5 KB
View Summary OPKO Submits Investigational New Drug Application to Initiate a Phase 2a Trial for its Long-Acting Coagulation Factor VIIa-CTP to Treat Hemophilia
Jan 30, 2015
PDF 11.8 KB
View Summary OPKO and Pfizer Receive Regulatory Clearance for Global Agreement
Jan 29, 2015
PDF 9.7 KB
View Summary OPKO Launches the 4Kscore Test in Mexico
Jan 28, 2015
PDF 12.2 KB
View Summary OPKO Claros1 Analyzer Selected for Development of a Rapid Lyme Disease Test Under Immuno Technologies NIH Grant
Jan 13, 2015
PDF 13.3 KB
View Summary OPKO Health to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Jan 5, 2015
PDF 7.9 KB
View Summary OPKO and Pfizer Enter into Global Agreement for OPKO's Long-Acting Human Growth Hormone (hGH-CTP)
Dec 15, 2014
PDF 16.9 KB
View Summary OPKO Health to Present at the Oppenheimer 25th Annual Healthcare Conference
Dec 3, 2014
PDF 8.5 KB
View Summary OPKO Health to Present at the Jefferies 2014 Global Healthcare Conference
Nov 13, 2014
PDF 7.7 KB
View Summary OPKO Announces Publication of Large, Prospective, Multi-Institutional Clinical Validation of the 4Kscore™ Test for High Grade Prostate Cancer in the United States
Nov 10, 2014
PDF 53.1 KB
View Summary OPKO To Hold Conference Call on November 10, 2014
Nov 7, 2014
PDF 10.2 KB
View Summary OPKO Announces Third Quarter Operating and Financial Results
Nov 7, 2014
PDF 24.2 KB
View Summary Neovasc, an OPKO Investee, Receives FDA Conditional Approval to Initiate TIARA-I Trial in U.S.: A Multinational, Multicenter Early Feasibility Trial of the TiaraTM Transcatheter Mitral Valve
Oct 9, 2014
PDF 12.8 KB
Showing 1-20 of 207 Page: 1 2 3 4 5 ... 11  Next 20